Please login to Zacks.com or register to post a comment.
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| SCIENTIFIC L | SCIL | 8.00% |
| NATUS MEDICA | BABY | 6.11% |
| SUMMER INFAN | SUMR | 6.02% |
| RADIANT LOGI | RLGT | 5.32% |
| NEW ORIENTAL | EDU | 4.51% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
OfficeMax Inc. ( OMX - Analyst Report ) is slated to report its second-quarter 2012 financial results on Thursday, August 2. The current Zacks Consensus Estimate for the quarter is 7 cents a share that remained flat with the prior-year quarter’s earnings.
The estimates in the current Zacks Consensus range between a low of 5 cents and a high of 8 cents a share. The Zacks Consensus Estimate for revenue is pegged at $1,638 million for the quarter under discussion.
Recap of First-Quarter 2012
OfficeMax posted better-than-expected first-quarter 2012 results. The quarterly earnings of 23 cents a share beat the Zacks Consensus Estimate of 16 cents and rose substantially from 13 cents earned in the prior-year quarter on the back of effective cost management and marginal growth in the top line.
Total sales inched up 0.5% to $1,872.9 million from the same quarter last year, and came ahead of the Zacks Consensus Estimate of $1,867 million.
OfficeMax Contract segment sales grew 3.8% to $960.6 million in the quarter, whereas Retail segment sales dipped 2.7% to $912.3 million, reflecting a decline of 2.1% in comparable-store sales due to lower store transactions.
Zacks Agreement & Magnitude
No movement was noticed in the Zacks Consensus Estimate for the second quarter either in the last 7 or 30 days, as the downward revision in the estimate made by 1 out of 10 analysts covering the stock in the respective periods did not have a material impact.
Earnings Surprise History
With respect to earnings surprises, OfficeMax has topped the Zacks Consensus Estimate by an average of 18.1% in the trailing four quarters. Given the past performance, we believe that OfficeMax may outperform the Zacks Consensus Estimate in the second quarter of 2012 as well.
Let’s Conclude
The change in the demand for office supplies products and services remains one of the indicators that describe the health of the economy. The economy has not completely awakened from a state of hibernation, and amid such a scenario OfficeMax has to walk the tight rope to juggle with any unprecedented situation that may restrict its growth prospects.
OfficeMax provides office supplies and paper, print and document services, technology products and solutions as well as office furniture to business firms, government organizations and other retail consumers.
As the recovery in the economy still remains sluggish, consumers and small businesses remain frugal about big-ticket spending like business machines and other durables. Therefore, we believe that the demand for office products is closely tied to the health of the economy.
Consequently, OfficeMax is repositioning itself to stay afloat amidst a difficult consumer environment. The company is containing costs, closing underperforming stores and focusing on innovative products and services, which should all contribute to margin improvements.
The company also focuses on optimal store sites in order to boost store productivity. Moreover, OfficeMax is committed to improve sales per square foot by increasing customer traffic and converting them into potential buyers by targeted advertising, ongoing sales training and customer-oriented initiatives. The company has initiated control center technology services to assist customers with PC maintenance or removal of viruses.
Genuine efforts are implemented to combat the tough economy. Business budgets remain tight, consumers remain cautious than ever before and companies are trying hard to navigate through the challenging maze.
Going by the pulse of the economy, we prefer to maintain our long-term Neutral recommendation on the stock. Moreover, OfficeMax, which competes with Office Depot Inc. ( ODP - Analyst Report ) and Staples Inc. ( SPLS - Analyst Report ) , holds a Zacks #3 Rank that translates into a short-term Hold rating.
Read the full reports :
Analyst Report on OMX
Analyst Report on ODP
Analyst Report on SPLS